NASHVILLE, Tenn., January 27, 2025--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced the launch of its "Harrow Cares" program through a strategic ...

Harrow's 11.875% Senior Notes due 2027 are attractive baby bonds with a healthy leverage percentage of 13.8%, indicating strong creditworthiness and low debt. Harrow funds operations through ...